Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lackner

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Expert Review of Gastroenterology & Hepatology|June 9, 2020
Skills over pills? A clinical gastroenterologist's primer in cognitive behavioral therapy for irritable bowel syndromeJeffrey M Lackner
Pain|February 7, 2024
Innovative cognitive behavioral therapies for irritable bowel syndrome: processes, predictors, platforms, and outcomesJeffrey M Lackner
Medizinische Klinik|February 22, 1977
[Comparison of the antibacterial efficacy of doxycycline and tetracycline (author's transl)]E Semenitz, M Lackner
Wiener Medizinische Wochenschrift (1946)|January 1, 1978
[Prazosin, a new antihypertensive agent]M Schoog, M Lackner
Wiener Medizinische Wochenschrift (1946)|January 1, 1978
[The antihypertensive therapy with prazosin in practice. Results of a multicenter study]M Lackner, E Schlinke
Zeitschrift Fur Allgemeinmedizin|April 20, 1971
[Studies on doxepin in general practice. (Report on 594 treated cases)]M Lackner, E Schlincke
Clinical and Translational Gastroenterology|October 16, 2015
Coping Flexibility, GI Symptoms, and Functional GI Disorders: How Translational Behavioral Medicine Research Can Inform GI PracticeChristopher Radziwon, Jeffrey M Lackner
Nature Reviews. Gastroenterology & Hepatology|June 28, 2019
Cognitive behavioural therapy for IBS: results or treatment as usual?Paul Enck, Jeffrey M Lackner
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel SyndromeJeffrey M Lackner, James Jaccard,
Therapeutics and Clinical Risk Management|August 30, 2008
Serotonin receptor modulators in the treatment of irritable bowel syndromeMohammad Fayyaz, Jeffrey M Lackner
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Expert Review of Gastroenterology & Hepatology|June 9, 2020
Skills over pills? A clinical gastroenterologist's primer in cognitive behavioral therapy for irritable bowel syndromeJeffrey M Lackner
Pain|February 7, 2024
Innovative cognitive behavioral therapies for irritable bowel syndrome: processes, predictors, platforms, and outcomesJeffrey M Lackner
Medizinische Klinik|February 22, 1977
[Comparison of the antibacterial efficacy of doxycycline and tetracycline (author's transl)]E Semenitz, M Lackner
Wiener Medizinische Wochenschrift (1946)|January 1, 1978
[Prazosin, a new antihypertensive agent]M Schoog, M Lackner
Wiener Medizinische Wochenschrift (1946)|January 1, 1978
[The antihypertensive therapy with prazosin in practice. Results of a multicenter study]M Lackner, E Schlinke
Zeitschrift Fur Allgemeinmedizin|April 20, 1971
[Studies on doxepin in general practice. (Report on 594 treated cases)]M Lackner, E Schlincke
Clinical and Translational Gastroenterology|October 16, 2015
Coping Flexibility, GI Symptoms, and Functional GI Disorders: How Translational Behavioral Medicine Research Can Inform GI PracticeChristopher Radziwon, Jeffrey M Lackner
Nature Reviews. Gastroenterology & Hepatology|June 28, 2019
Cognitive behavioural therapy for IBS: results or treatment as usual?Paul Enck, Jeffrey M Lackner
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel SyndromeJeffrey M Lackner, James Jaccard,
Therapeutics and Clinical Risk Management|August 30, 2008
Serotonin receptor modulators in the treatment of irritable bowel syndromeMohammad Fayyaz, Jeffrey M Lackner
Pageof 17